A Retrospective Cohort Analysis of SMARCA4-Deficient Lung Cancer

NCT07121387 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 221

Last updated 2025-08-13

No results posted yet for this study

Summary

This is a single-center retrospective analysis to explore the clinical characteristics, therapeutic efficacy, and tumor immune microenvironment of SMARCA4-deficient advanced non-small-cell lung cancer (NSCLC).

Conditions

  • SMARCA4-Deficient Tumor
  • NSCLC (Advanced Non-small Cell Lung Cancer)

Sponsors & Collaborators

  • Shanghai Pulmonary Hospital, Shanghai, China

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2024-12-17
Completion
2024-12-17

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07121387 on ClinicalTrials.gov